🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Imricor Medical Systems, Inc. (ASX:IMR)
Australia flag Australia · Delayed Price · Currency is AUD
1.325
+0.015 (1.15%)
Nov 20, 2026, 4:10 PM AEDT

Imricor Medical Systems Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
0.270.290.960.620.820.7
Revenue Growth
-46.19%-69.53%55.86%-24.56%17.20%-0.84%
Cost of Revenue
2.822.331.881.732.342.59
Gross Profit
-2.55-2.03-0.92-1.12-1.53-1.9
Selling, General & Admin
12.469.67.197.827.798.69
Research & Development
14.8111.168.187.927.959.68
Operating Expenses
27.2720.7615.3715.7415.7318.36
Operating Income
-29.82-22.79-16.3-16.86-17.26-20.26
Interest Expense
--0-0.02-0.05-0.18-0.11
Interest & Investment Income
1.491.180.260.060.110.02
Currency Exchange Gain (Loss)
0.281.510.20.01-0.02-0.04
Other Non Operating Income (Expenses)
-1.82-0.07-2.42-5.79-0.01-0.1
EBT Excluding Unusual Items
-29.87-20.17-18.28-22.63-17.36-20.49
Other Unusual Items
-6.86-5.14-11.42--0.76
Pretax Income
-36.73-25.32-29.69-22.63-17.36-19.73
Net Income
-36.73-25.32-29.69-22.63-17.36-19.73
Net Income to Common
-36.73-25.32-29.69-22.63-17.36-19.73
Net Income Growth
------
Shares Outstanding (Basic)
335309224157146131
Shares Outstanding (Diluted)
335309224157146131
Shares Change
14.46%37.84%43.03%7.46%11.42%18.76%
EPS (Basic)
-0.11-0.08-0.13-0.14-0.12-0.15
EPS (Diluted)
-0.11-0.08-0.13-0.14-0.12-0.15
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-27.4-19.52-15.65-13.06-16.75-18.11
Free Cash Flow Per Share
-0.08-0.06-0.07-0.08-0.12-0.14
Gross Margin
---96.32%-181.27%-187.10%-272.30%
Operating Margin
-10918.82%-7796.87%-1698.60%-2738.12%-2115.18%-2909.72%
Profit Margin
-13450.09%-8661.58%-3094.86%-3675.61%-2126.96%-2834.05%
Free Cash Flow Margin
-10031.44%-6676.31%-1631.38%-2121.66%-2052.56%-2601.63%
EBITDA
-29.09-21.99-15.55-16.15-16.55-19.57
D&A For EBITDA
0.720.80.750.710.710.69
EBIT
-29.82-22.79-16.3-16.86-17.26-20.26
Revenue as Reported
0.290.290.960.620.820.7